Contact Us News & Media Font Size Home About Us Products Research Responsibility Investor Relations News & Media Careers MARK TRUDEAU Core Strengths Executive Team Board of Directors Melvin Booth Mark Trudeau David Carlucci J. Martin Carroll Diane Gulyas David Norton JoAnn Reed Angus Russell Kneeland Youngblood, M.D. Joseph Zaccagnino 150th Anniversary Our Story Inclusion and Diversity Partnering News & Media Blog Patient Stories Careers at Mallinckrodt Community Outreach Investor Relations Mark Trudeau President and Chief Executive Officer Mr. Trudeau has been president, chief executive officer and a director since June 2013. In anticipation of Mallinckrodt’s spin transaction with Covidien plc, Mr. Trudeau joined Covidien in February 2012 as a senior vice president and president of its Pharmaceuticals business. He joined Covidien from Bayer HealthCare LLC, the U.S. healthcare business of Bayer AG, where he served as chief executive officer from 2010 to 2012. In addition, he served as president of the global specialty medicine business unit in 2010. Prior to joining Bayer in 2009, Mr. Trudeau headed the Immunoscience Division at Bristol-Myers Squibb. During his 10-plus years at Bristol-Myers Squibb, he served in multiple senior roles, including president of the Asia/Pacific region, president and general manager of Canada, and general manager/managing director in the United Kingdom. Mr. Trudeau was also with Abbott Laboratories, serving in a variety of executive positions, from 1988 to 1998. Mr. Trudeau became a member of the TE Connectivity Ltd. board of directors in 2016. He was appointed a trustee of the Donald Danforth Plant Science Center in St. Louis in December 2013. Mr. Trudeau holds a bachelor’s degree in chemical engineering and an MBA, both from the University of Michigan. Back Building On Our Heritage Nearly 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Resources for: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn